Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443020) titled 'Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Condition:
Malignant Pleural Effusion
Malignant Mesothelioma
Pleural Effusion, Malignant
Metastasis to Pleura
Intervention:
Biological: locally manufactured adoptive cellular therapy (ACT) product
Recruitment Status: Not recruiting
Pha...